Related Experiment Video
Updated: Nov 4, 2025

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
The international Pediatric Oncology Exercise Guidelines (iPOEG)
Amanda Wurz1, Emma McLaughlin1, Conné Lategan1
1Faculty of Kinesiology, University of Calgary, Calgary, Canada.
Physical activity is safe and beneficial for pediatric cancer patients, but they remain inactive. The international Pediatric Oncology Exercise Guidelines (iPOEG) were developed to promote movement in this population.
Area of Science:
- Pediatric Oncology
- Exercise Science
- Public Health
Background:
- Physical activity (PA) and exercise are safe and beneficial for children and adolescents with cancer.
- This population is currently not active enough to gain health benefits.
- PA guidelines can drive behavior change and improve practice.
Purpose of the Study:
- To develop the international Pediatric Oncology Exercise Guidelines (iPOEG).
- To create guideline and recommendation statements promoting PA in pediatric cancer patients.
Main Methods:
- Guideline development procedures, stakeholder engagement, and the Delphi technique were employed.
- Four online surveys were distributed to an expert network (n=131).
- Responses were analyzed using descriptive statistics and content analysis, with consensus defined as ≥80% agreement.
Main Results:
- The iPOEG network reached consensus on four guideline and five recommendation statements.
- Statements emphasize the importance of movement for all children and adolescents affected by cancer.
- Current statements are generic, acknowledging the need for more research on specific PA parameters.
Conclusions:
- The iPOEG statements represent current evidence and expert opinion.
- There is a collective call to action for increased physical activity in pediatric cancer patients.
- Further research is needed to provide specific PA guidance for this population.
More Related Videos
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
International Nursing Organizations I
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
Treatment Resistant Cancers
Interpersonal Psychotherapy
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...

